Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men

Overview of attention for article published in Scientific Reports, June 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 2 X users

patent: 7 patents

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment…

Grant US-11326210-B2

United States of America

10 May 2022

NOVEL BIOMARKERS AND DIAGNOSTIC PROFILES FOR PROSTATE CANCER INTEGRATING CLINICAL…

Application WO-2021048445-A1

World Intellectual Property Organisation (WIPO)

18 Mar 2021

MONOCLONAL ANTIBODY OBTAINED FROM SPECIFIC ANTIGEN SPECIFICALLY RECOGNIZING EN2 PROTEIN…

Application WO-2019013392-A1

World Intellectual Property Organisation (WIPO)

17 Jan 2019

MONOCLONAL ANTIBODY THAT SPECIFICALLY RECOGNIZES EN2 PROTEIN OR COMPOSITION FOR…

Application WO-2019013394-A1

World Intellectual Property Organisation (WIPO)

17 Jan 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.